InterVest Co., Ltd.

Established in 1999, InterVest Co., Ltd. is a prominent venture capital firm based in Seoul, South Korea, focusing on technology and biotechnology sectors. The firm has a history of supporting startups and early-stage businesses, providing pre-initial public offering financing through mezzanine and bridge transactions. InterVest has raised multiple funds, including the InterVest Star Southeast Asia Growth Fund I in 2017, with a total of $100 million.

InterVest's investment strategy emphasizes sectors such as biotechnology, healthcare, semiconductor, fintech, blockchain, and various digital technologies. The firm has a track record of notable exits, including Lunit, Alchera, and Orum Therapeutics. As of 2021, InterVest's assets under management were reported to be over $1.4 billion, reflecting its significant presence in the venture capital landscape.

The firm's investment philosophy centers on courage, aiming to evaluate risks objectively, confront fears, and prepare for upcoming market challenges. This approach has positioned InterVest as a reliable partner for ventures seeking sustainable and scalable growth in the competitive South Korean market.